Immediate Impact
4 from Science/Nature 81 standout
Citing Papers
Polymeric Nanoparticles for Drug Delivery
2024 Standout
Ulcerative colitis
2023 Standout
Works of Carol Greenlees being referenced
A phase I, open-label, first-time-in-patient dose escalation and expansion study to assess the safety, tolerability, and pharmacokinetics of nanoparticle encapsulated Aurora B kinase inhibitor AZD2811 in patients with advanced solid tumours.
2017
A randomized placebo-controlled trial of a humanized monoclonal antibody to α4 integrin in active crohn's disease
2001
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Carol Greenlees | 55 | 13 | 16 | 280 | 177 | 11 | 461 | |
| Laura Maximiliane Ehmann | 59 | 9 | 23 | 173 | 93 | 16 | 423 | |
| T Kirkegaard | 159 | 36 | 14 | 198 | 70 | 10 | 514 | |
| M. Niessner | 60 | 37 | 4 | 186 | 131 | 8 | 473 | |
| CA Mullen | 126 | 34 | 43 | 199 | 108 | 13 | 478 | |
| J T Dancey | 99 | 34 | 8 | 167 | 47 | 12 | 575 | |
| Emancipator Sn | 81 | 27 | 13 | 76 | 41 | 10 | 420 | |
| Sean P. McCarthy | 179 | 46 | 63 | 80 | 143 | 9 | 526 | |
| Matthew Schrage | 152 | 124 | 8 | 55 | 85 | 12 | 569 | |
| Christopher Eichman | 188 | 14 | 26 | 57 | 85 | 12 | 563 | |
| F S Rosen | 208 | 18 | 54 | 62 | 76 | 16 | 555 |
All Works
Loading papers...